See more : DW8 Limited (DW8.AX) Income Statement Analysis – Financial Results
Complete financial analysis of MERCK Kommanditgesellschaft auf Aktien (MRK.DE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MERCK Kommanditgesellschaft auf Aktien, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Idarado Mining Company (IDAM) Income Statement Analysis – Financial Results
- America’s Car-Mart, Inc. (CRMT) Income Statement Analysis – Financial Results
- The Torrington Water Company (TORW) Income Statement Analysis – Financial Results
- Asia Standard Hotel Group Limited (0292.HK) Income Statement Analysis – Financial Results
- Prismo Metals Inc. (PMOMF) Income Statement Analysis – Financial Results
MERCK Kommanditgesellschaft auf Aktien (MRK.DE)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.merckgroup.com
About MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 20.99B | 22.23B | 19.69B | 17.53B | 16.15B | 14.84B | 15.33B | 15.02B | 12.84B | 11.50B | 11.10B | 11.17B | 10.28B | 9.29B | 7.75B | 7.56B | 7.06B | 6.26B | 5.87B | 5.34B | 7.20B | 7.40B |
| Cost of Revenue | 9.32B | 8.53B | 7.35B | 6.84B | 6.01B | 5.38B | 5.32B | 5.20B | 4.08B | 4.06B | 3.56B | 3.74B | 2.79B | 2.39B | 2.03B | 1.91B | 1.78B | 2.41B | 2.37B | 2.25B | 3.57B | 3.79B |
| Gross Profit | 11.67B | 13.71B | 12.34B | 10.70B | 10.15B | 9.45B | 10.01B | 9.82B | 8.77B | 7.44B | 7.54B | 7.44B | 7.49B | 6.91B | 5.72B | 5.65B | 5.28B | 3.84B | 3.50B | 3.09B | 3.63B | 3.61B |
| Gross Profit Ratio | 55.59% | 61.65% | 62.66% | 61.02% | 62.82% | 63.72% | 65.29% | 65.38% | 68.26% | 64.66% | 67.92% | 66.55% | 72.87% | 74.32% | 73.81% | 74.78% | 74.78% | 61.43% | 59.64% | 57.87% | 50.40% | 48.72% |
| Research & Development | 2.45B | 2.52B | 2.41B | 2.29B | 2.27B | 2.23B | 2.14B | 1.98B | 1.71B | 1.70B | 1.50B | 1.51B | 1.52B | 1.40B | 1.34B | 1.23B | 1.03B | 751.60M | 713.00M | 599.00M | 604.60M | 608.20M |
| General & Administrative | 1.39B | 1.31B | 1.24B | 1.19B | 1.15B | 993.00M | 930.00M | 854.00M | 719.90M | 608.60M | 562.40M | 552.20M | 1.01B | 478.20M | 424.90M | 446.20M | 444.70M | 386.70M | 354.70M | 329.20M | 412.40M | 468.00M |
| Selling & Marketing | 3.91B | 4.10B | 3.71B | 3.57B | 3.65B | 3.41B | 3.69B | 3.50B | 3.27B | 2.39B | 2.33B | 2.41B | 2.39B | 2.23B | 2.27B | 2.10B | 1.93B | 1.48B | 1.47B | 1.34B | 1.72B | 1.77B |
| SG&A | 5.31B | 5.40B | 4.96B | 4.76B | 4.81B | 4.40B | 4.62B | 4.35B | 3.99B | 2.99B | 2.89B | 2.96B | 3.40B | 2.71B | 2.70B | 2.54B | 2.38B | 1.86B | 1.82B | 1.67B | 2.13B | 2.24B |
| Other Expenses | 595.00M | 1.03B | 777.00M | 841.00M | 767.00M | 521.00M | 681.00M | 431.00M | 342.80M | 65.80M | 62.70M | 70.80M | 1.59B | 1.69B | 1.03B | 743.40M | 896.50M | 125.60M | 84.00M | -217.30M | 311.60M | 263.90M |
| Operating Expenses | 8.78B | 8.95B | 8.14B | 7.89B | 7.84B | 7.58B | 7.63B | 7.53B | 6.60B | 5.68B | 5.38B | 5.55B | 6.50B | 5.80B | 5.07B | 4.52B | 4.30B | 2.74B | 2.62B | 2.05B | 3.05B | 3.11B |
| Cost & Expenses | 17.38B | 17.48B | 15.49B | 14.72B | 13.85B | 12.97B | 12.95B | 12.73B | 10.68B | 9.74B | 8.94B | 9.28B | 9.29B | 8.19B | 7.10B | 6.43B | 6.08B | 5.15B | 4.99B | 4.30B | 6.62B | 6.90B |
| Interest Income | 121.00M | 71.00M | 46.00M | 39.00M | 66.00M | 55.00M | 26.00M | 20.00M | 32.00M | 30.60M | 30.10M | 35.60M | 57.80M | -38.60M | -42.30M | -71.50M | 10.60M | 1.60M | 31.40M | -39.20M | 0.00 | 0.00 |
| Interest Expense | 272.00M | 235.00M | 272.00M | 387.00M | 476.00M | 339.00M | 348.00M | 342.00M | 348.80M | 222.70M | 248.00M | 301.20M | 319.10M | 208.90M | 88.70M | 84.90M | 321.90M | 50.60M | 33.60M | 43.50M | 0.00 | 0.00 |
| Depreciation & Amortization | 1.88B | 1.80B | 1.71B | 1.76B | 1.91B | 1.75B | 1.76B | 1.81B | 1.51B | 1.36B | 1.46B | 1.40B | 1.60B | 1.26B | 1.00B | 1.22B | 923.60M | 303.00M | 289.50M | 375.00M | 470.50M | 425.20M |
| EBITDA | 5.69B | 6.28B | 5.88B | 4.78B | 4.12B | 3.46B | 4.17B | 4.24B | 3.62B | 3.14B | 3.10B | 3.27B | 2.76B | 2.36B | 1.65B | 2.35B | 1.13B | 1.10B | 1.17B | 1.12B | 1.01B | 920.00M |
| EBITDA Ratio | 27.08% | 30.33% | 30.28% | 26.97% | 26.18% | 25.00% | 27.29% | 27.90% | 28.19% | 27.73% | 33.03% | 29.29% | 23.65% | 25.45% | 21.65% | 36.34% | 37.90% | 19.00% | 18.72% | 26.57% | 17.32% | 13.20% |
| Operating Income | 3.61B | 4.47B | 4.18B | 2.99B | 2.12B | 1.73B | 2.53B | 2.48B | 1.84B | 1.76B | 1.61B | 963.60M | 985.10M | 1.11B | 620.90M | 731.40M | 975.70M | 1.11B | 955.60M | 1.04B | 579.30M | 494.80M |
| Operating Income Ratio | 17.19% | 20.12% | 21.23% | 17.02% | 13.13% | 11.64% | 16.47% | 16.51% | 14.35% | 15.32% | 14.52% | 8.62% | 9.59% | 11.94% | 8.01% | 9.68% | 13.83% | 17.67% | 16.28% | 19.54% | 8.04% | 6.69% |
| Total Other Income/Expenses | -125.00M | -187.00M | -255.00M | -355.00M | -385.00M | -266.00M | -294.00M | -327.00M | -356.50M | -205.00M | -222.20M | -1.13B | -293.30M | -248.30M | -159.00M | -535.90M | -1.09B | 577.10M | 11.90M | -82.70M | -156.70M | -83.20M |
| Income Before Tax | 3.48B | 4.29B | 3.92B | 2.63B | 1.74B | 1.46B | 2.22B | 2.15B | 1.49B | 1.56B | 1.39B | 709.00M | 851.10M | 861.10M | 486.40M | 574.90M | -110.90M | 1.27B | 893.40M | 960.80M | 422.60M | 411.60M |
| Income Before Tax Ratio | 16.60% | 19.28% | 19.93% | 15.00% | 10.74% | 9.85% | 14.51% | 14.34% | 11.57% | 13.54% | 12.52% | 6.35% | 8.28% | 9.27% | 6.28% | 7.61% | -1.57% | 20.35% | 15.22% | 17.99% | 5.87% | 5.56% |
| Income Tax Expense | 650.00M | 948.00M | 859.00M | 637.00M | 440.00M | 368.00M | -386.00M | 521.00M | 368.00M | 392.20M | 179.50M | 130.00M | 222.10M | 219.60M | 109.70M | 195.80M | -23.10M | 272.20M | 220.70M | 288.90M | 204.90M | 196.40M |
| Net Income | 2.82B | 3.33B | 3.06B | 1.99B | 1.32B | 3.37B | 2.60B | 1.63B | 1.11B | 1.16B | 1.20B | 566.70M | 629.00M | 641.50M | 376.70M | 379.10M | 3.52B | 1.00B | 672.70M | 671.90M | 217.70M | 215.20M |
| Net Income Ratio | 13.45% | 14.96% | 15.52% | 11.33% | 8.17% | 22.74% | 16.96% | 10.84% | 8.68% | 10.06% | 10.84% | 5.07% | 6.12% | 6.90% | 4.86% | 5.02% | 49.88% | 16.00% | 11.46% | 12.58% | 3.02% | 2.91% |
| EPS | 6.50 | 7.65 | 7.03 | 4.57 | 3.04 | 7.76 | 5.99 | 3.75 | 2.56 | 2.66 | 2.77 | 1.31 | 1.40 | 1.46 | 0.84 | 0.85 | 8.11 | 2.54 | 1.67 | 1.71 | 0.57 | 0.58 |
| EPS Diluted | 6.50 | 7.65 | 7.03 | 4.57 | 3.04 | 7.76 | 5.99 | 3.75 | 2.56 | 2.66 | 2.77 | 1.31 | 1.40 | 1.46 | 0.84 | 0.85 | 8.11 | 2.54 | 1.67 | 1.71 | 0.57 | 0.58 |
| Weighted Avg Shares Out | 434.78M | 434.78M | 434.78M | 434.78M | 434.78M | 434.78M | 434.78M | 434.40M | 434.78M | 435.08M | 434.01M | 434.25M | 434.77M | 434.80M | 434.80M | 434.80M | 431.80M | 388.00M | 393.65M | 385.12M | 366.84M | 349.37M |
| Weighted Avg Shares Out (Dil) | 434.78M | 434.78M | 434.78M | 434.78M | 434.78M | 434.78M | 434.89M | 434.40M | 435.55M | 435.08M | 434.01M | 434.25M | 434.77M | 434.80M | 434.80M | 434.80M | 431.80M | 388.00M | 393.65M | 385.12M | 366.84M | 349.37M |
Source: https://incomestatements.info
Category: Stock Reports